Chad Landmon

Polsinelli

+ Follow Contact

Latest Posts › Listing Standards

Share:

The FTC’s Challenge to the Listing of Device Patents in the Orange Book: What Challenge?

On September 23, 2023, the FTC issued a policy statement advising it would be putting market participants on notice that it intends to scrutinize improper Orange Book listings to determine whether such actions constitute...more

7/18/2024 / Antitrust Provisions , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , Listing Standards , Medical Devices , Orange Book , Pharmaceutical Industry , Pharmaceutical Patents , Unfair Competition

1 Results

View per page

Page: of 1

Chad Landmon

Polsinelli

Popular Topics by This Author

Latest Posts › Listing Standards

The FTC’s Challenge to the Listing of Device Patents in the Orange Book: What Challenge?

"My best business intelligence, in one easy email…"